Clinical Translation Research on a Multi-omics Breast Cancer Distant Metastasis Prediction Model Empowered by Artificial Intelligence
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Breast cancer is one of the most common malignancies in women worldwide, and distant metastasis is the main cause of poor prognosis and death. This project aims to construct a precision prediction system based on multi-omics (digital pathology, immunohistochemistry, proteomics, gene sequencing) and artificial intelligence to predict distant and organ-specific metastasis (bone, lung, liver, brain) in breast cancer, analyze its mechanisms, and provide new solutions for precision medicine.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pacjentki z potwierdzoną diagnozą raka piersi postawioną w naszym szpitalu lub ośrodkach partnerskich między rokiem 2000 a 2028
- •Rak piersi rozprzestrzeniał się na odległe części ciała (wątroba, kości, płuca lub mózg) i posiadamy próbkę tkanki z tego miejsca przechowywane w naszym szpitalu
- •Posiadamy kompletne informacje medyczne pacjentki dotyczące jej choroby
✗ Disqualifies
- •Równoczesne występowanie innego rodzaju nowotworu złośliwego z innego źródła
- •Brak kompletnych informacji medycznych pacjentki
Simplified criteria — AI translation
Trial details
- Last updated (source)
- March 3, 2026
- Sex
- Female only
Locations (1)
The Second Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, China
Trial contact
Fengbo Huang, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.